Cancer Family
Malignant Digestive System Neoplasm
CI-CAN-00000229Explore in graph →
4,262 active trials43 approved drugs556 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000229Explore in graph →
Clinical trials
19,108 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (2,001)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00890188 | Thalidomide and Tegafur/Uracil(UFUR) in the Treatment of Advanced Colorectal Cancer(UFUR) | unknown | Phase 2 | 34 | National Cheng-Kung University HospitalOTHER | 1 | May 7, 2009 | clinicaltrials |
| NCT00894725 | Laparoscopic Versus Open Left Colonic Resection | completed | Phase 3 | 268 | Università Vita-Salute San RaffaeleOTHER | 1 | May 7, 2009 | clinicaltrials |
| NCT00099294 | Study of the Efficacy and Safety of Glufosfamide Compared With Best Supportive Care in Metastatic Pancreatic Cancer | completed | Phase 3 | 300 | Threshold PharmaceuticalsINDUSTRY | 11 | Apr 30, 2009 | clinicaltrials |
| NCT00096707 | Dose Escalation Trial of 2-Deoxy-D-Glucose (2DG) in Subjects With Advanced Solid Tumors | completed | Phase 1 | 50 | Threshold PharmaceuticalsINDUSTRY | 1 | Apr 29, 2009 | clinicaltrials |
| NCT00102700 | ARQ 501 in Combination With Gemcitabine in Subjects With Pancreatic Cancer | completed | Phase 2 | 66 | ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA)INDUSTRY | 1 | Apr 29, 2009 | clinicaltrials |
| NCT00123851 | Tarceva, Capecitabine and Oxaliplatin for Metastatic Colorectal Cancer | completed | Phase 2 | 32 | Dana-Farber Cancer InstituteOTHER | 1 | Apr 28, 2009 | clinicaltrials |
| NCT00165191 | Doxorubicin, Cisplatin, 5-Fluorouracil in Patients With Advanced Adenocarcinoma of the Stomach or Esophagus | completed | Phase 2 | 32 | Dana-Farber Cancer InstituteOTHER | 1 | Apr 28, 2009 | clinicaltrials |
| NCT00165464 | Taxotere, Cisplatin and Irinotecan (CPT-11) for Esophagogastric Cancer | completed | Phase 2 | 54 | Dana-Farber Cancer InstituteOTHER | 1 | Apr 28, 2009 | clinicaltrials |
| NCT00215462 | Vinorelbine in Unresectable or Metastatic Esophageal and Gastric Adenocarcinoma | completed | Phase 2 | 32 | Dana-Farber Cancer InstituteOTHER | 1 | Apr 28, 2009 | clinicaltrials |
| NCT00234416 | IRESSA Combined With Radiotherapy & Gemcitabine as First-Line Treatment in Locally Advanced Pancreatic Cancer | completed | Phase 1 / Phase 2 | 45 | AstraZenecaINDUSTRY | 1 | Apr 23, 2009 | clinicaltrials |
| NCT00242788 | IRESSA™ In Combo With Xeloda™ in Advanced Colorectal Cancer Patients After 1st-Line Chemo Failure | completed | Phase 1 / Phase 2 | 40 | AstraZenecaINDUSTRY | 1 | Apr 23, 2009 | clinicaltrials |
| NCT00885248 | Integrated Positron Emission Tomography - Computed Tomography (PET-CT) in Patients With Pancreatic Cancer | unknown | — | 70 | Asan Medical CenterOTHER | 1 | Apr 21, 2009 | clinicaltrials |
| NCT00883454 | Estimation of Functional Liver Reserve Using Cholinesterases | completed | — | 181 | University of MilanOTHER | 1 | Apr 17, 2009 | clinicaltrials |
| NCT00639522 | Dose Escalation Study of Liposomal Paclitaxel With/Without Capecitabine in Patients With Advanced Gastric Carcinoma | unknown | Phase 1 | 18 | Nanjing Sike Pharmaceutical Co., Ltd.INDUSTRY | 1 | Apr 15, 2009 | clinicaltrials |
| NCT00881816 | Dose Escalation Study of Liposomal Paclitaxel Plus Capecitabine in Chinese Patients With Advanced Gastric Carcinoma | unknown | Phase 1 | 15 | Nanjing Sike Pharmaceutical Co., Ltd.INDUSTRY | 0 | Apr 15, 2009 | clinicaltrials |
| NCT00254683 | Use of Positron Emission Tomography/Computed Tomography (PET/CT) to Assess Tumor Response to Neoadjuvant Treatment for Distal Rectal Cancer | unknown | Phase 2 | 100 | University of Sao PauloOTHER | 1 | Apr 14, 2009 | clinicaltrials |
| NCT00842647 | Diagnosis of Hepatic Tumors in Cirrhosis: Prospective Validation of the Noninvasive Diagnostic Criteria for Hepatocellular Carcinoma(HCC) | unknown | — | 1,200 | Sun Yat-sen UniversityOTHER | 1 | Apr 8, 2009 | clinicaltrials |
| NCT00874406 | Preoperative Transhepatic Arterial Chemotherapy (TAC) in the Treatment of Liver Metastasis of Resectable Colorectal Cancer | unknown | Phase 4 | 100 | Fudan UniversityOTHER | 1 | Apr 2, 2009 | clinicaltrials |
| NCT00555334 | Nucleoid as an Adjuvant Therapy After Radiofrequency Ablation for Hepatocellular Carcinoma(LAM-RFA) | unknown | Phase 4 | 200 | Sun Yat-sen UniversityOTHER | 1 | Apr 1, 2009 | clinicaltrials |
| NCT00379132 | 131-I-TM-601 Study in Adults With Solid Tumors | completed | Phase 1 | 60 | TransMolecularINDUSTRY | 1 | Mar 31, 2009 | clinicaltrials |
| NCT00485316 | Laparoscopic Assisted Versus Open Resection for Colorectal Carcinoma | completed | Phase 3 | — | Chinese University of Hong KongOTHER | 1 | Mar 31, 2009 | clinicaltrials |
| NCT00094965 | Oxaliplatin With FOLFOX4 in Patients With Normal and Abnormal Renal Function(FOLFOX4) | completed | Phase 2 | 43 | SanofiINDUSTRY | 1 | Mar 30, 2009 | clinicaltrials |
| NCT00868569 | Transhepatic Arterial Chemotherapy (TAC) Versus Transcatheter Arterial Chemoembolization (TACE) Plus Folfox4 as the Treatment of Unresectable Liver Metastasis of Colorectal Cancer | unknown | Phase 4 | 200 | Fudan UniversityOTHER | 1 | Mar 25, 2009 | clinicaltrials |
| NCT00868816 | Oxaliplatine Based Adjuvant Chemotherapy for Stage II/III Colorectal Cancer: 8 Cycles Versus 12 Cycles | completed | Phase 4 | 400 | Fudan UniversityOTHER | 1 | Mar 25, 2009 | clinicaltrials |
| NCT00588549 | Utility of PET In the Pre-Operative Assessment of Patients With Hepatic Colorectal Metastases | completed | — | 204 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Mar 19, 2009 | clinicaltrials |
| NCT00605800 | Bone Marrow Derived Adult Liver Stem Cell Recruitment After Major Liver Resections: Correlation With Liver Regeneration and Hepatic Function | withdrawn | — | 0 | Memorial Sloan Kettering Cancer CenterOTHER | 0 | Mar 19, 2009 | clinicaltrials |
| NCT00860665 | Case Volume and Adenoma Rate During Screening Colonoscopy | completed | — | 12,134 | Charite University, Berlin, GermanyOTHER | 1 | Mar 12, 2009 | clinicaltrials |
| NCT00291473 | Safety and Immunogenicity of CHP-HER2 and CHP-NY-ESO-1 Protein With OK-432 in Antigen-Expressing Cancers | completed | Phase 1 | 9 | Ludwig Institute for Cancer ResearchOTHER | 1 | Mar 3, 2009 | clinicaltrials |
| NCT00153998 | Cetuximab in Neoadjuvant Treatment of Non-Resectable Colorectal Liver Metastases (CELIM) | completed | Phase 2 | 135 | Technische Universität DresdenOTHER | 2 | Feb 27, 2009 | clinicaltrials |
| NCT00422773 | Safety of Cetuximab and Oxaliplatin/5-FU/FA/Irinotecan in First-Line Treatment of Metastatic Colorectal Cancer | completed | Phase 1 / Phase 2 | 21 | Technische Universität DresdenOTHER | 1 | Feb 27, 2009 | clinicaltrials |
| NCT00259532 | Three New Methods for Diagnosing Pancreas Cancer | unknown | N/A | 80 | University of CopenhagenOTHER | 1 | Feb 26, 2009 | clinicaltrials |
| NCT00619541 | Study of Sorafenib and Infusional 5-Fluorouracil in Advanced Hepatocellular Carcinoma (HCC)(P2) | completed | Phase 2 | 46 | Italian Trial in Medical OncologyOTHER | 1 | Feb 26, 2009 | clinicaltrials |
| NCT00197444 | Low-Dose Nedaplatin (CDGP:Cis-Diammine-Glycolatoplatinum)/5-FU Combined With Radiation for Esophageal Cancer | completed | Phase 2 | 33 | Hamamatsu UniversityOTHER | 1 | Feb 20, 2009 | clinicaltrials |
| NCT00585845 | Study of Safety and Tolerability of Intravenous CRS-207 in Adults With Selected Advanced Solid Tumors Who Have Failed or Who Are Not Candidates for Standard Treatment | terminated | Phase 1 | 17 | Anza Therapeutics, Inc.INDUSTRY | 2 | Feb 20, 2009 | clinicaltrials |
| NCT00848094 | Radiation Dose Escalation Study for Advanced Liver Cancer | completed | Phase 1 | 40 | Fudan UniversityOTHER | 0 | Feb 20, 2009 | clinicaltrials |
| NCT00024375 | DHA-Paclitaxel in Treating Patients With Metastatic Pancreatic Cancer | unknown | Phase 2 | — | TheradexINDUSTRY | 4 | Feb 18, 2009 | clinicaltrials |
| NCT00622622 | Gemcitabine With Antiangiogenic Peptide Vaccine Therapy in Patients With Pancreatic Cancer | completed | Phase 1 | 21 | Wakayama Medical UniversityOTHER | 1 | Feb 18, 2009 | clinicaltrials |
| NCT00738478 | Quality of Life After Routine Nasogastric Decompression After Distal Gastrectomy for Gastric Cancer Patients | completed | Phase 3 | 180 | Wakayama Medical UniversityOTHER | 1 | Feb 18, 2009 | clinicaltrials |
| NCT00845884 | Phase I/II Study of Weekly Docetaxel and Cisplatin Together With Capecitabine and Bevacizumab in Advanced Gastric Cancer | unknown | Phase 1 / Phase 2 | 49 | Rabin Medical CenterOTHER | 1 | Feb 18, 2009 | clinicaltrials |
| NCT00209612 | Phase I/II Study of Paclitaxel Plus CPT-11 in Pts. With 2nd Line Chemotherapy of Inoperable or Recurrent GC. | withdrawn | Phase 1 / Phase 2 | 40 | Hokkaido Gastrointestinal Cancer Study GroupOTHER | 1 | Feb 17, 2009 | clinicaltrials |
| NCT00611000 | Effect of Folate on DNA in Colon Tissue and Blood Samples From Patients at Increased Risk of Developing Colorectal Neoplasia | completed | Phase 1 | 20 | Rockefeller UniversityOTHER | 0 | Feb 17, 2009 | clinicaltrials |
| NCT00844688 | Study of Sorafenib and Gemcitabine in Advanced Hepatocellular Carcinoma (HCC)(HCC) | unknown | Phase 2 | 30 | Combined Military Hospital, PakistanOTHER | 1 | Feb 16, 2009 | clinicaltrials |
| NCT00129870 | CONCEPT: Comparison of Oxaliplatin vs Conventional Methods With Calcium/Magnesium in First-Line Metastatic Colorectal Cancer | terminated | Phase 4 | 180 | SanofiINDUSTRY | 1 | Feb 13, 2009 | clinicaltrials |
| NCT00841282 | RCT of Air Insufflation Versus Water Infusion Colonoscopy by Supervised Trainees | completed | N/A | 62 | East Bay Institute for Research and EducationOTHER | 1 | Feb 11, 2009 | clinicaltrials |
| NCT00554905 | Radiofrequency Ablation With or With Transcatheter Arterial Embolization for Hepatocellular Carcinoma(RFA and TACE) | unknown | Phase 4 | 180 | Sun Yat-sen UniversityOTHER | 1 | Feb 10, 2009 | clinicaltrials |
| NCT00008047 | Combination Chemotherapy Combined With Radiation Therapy in Treating Patients Who Have Stage II or Stage III Cancer of the Esophagus | unknown | Phase 1 / Phase 2 | — | GERCOR - Multidisciplinary Oncology Cooperative GroupOTHER | 1 | Feb 9, 2009 | clinicaltrials |
| NCT00010062 | Fluorouracil Plus Radiation Therapy Following Surgery in Treating Patients With Pancreatic Cancer | unknown | Phase 2 | — | GERCOR - Multidisciplinary Oncology Cooperative GroupOTHER | 2 | Feb 9, 2009 | clinicaltrials |
| NCT00010088 | Chemotherapy in Treating Patients With Locally Advanced or Metastatic Cancer of the Pancreas or Bile Duct | unknown | Phase 2 | — | GERCOR - Multidisciplinary Oncology Cooperative GroupOTHER | 2 | Feb 9, 2009 | clinicaltrials |
| NCT00072553 | Celecoxib, Leucovorin, Fluorouracil, and Oxaliplatin in Treating Patients With Metastatic Colorectal Cancer | unknown | Phase 2 | — | GERCOR - Multidisciplinary Oncology Cooperative GroupOTHER | 1 | Feb 9, 2009 | clinicaltrials |
| NCT00075556 | Neoadjuvant Radiation Therapy and Capecitabine in Treating Patients With Stage III or Stage IV Colorectal Adenocarcinoma | unknown | Phase 2 | — | GERCOR - Multidisciplinary Oncology Cooperative GroupOTHER | 1 | Feb 9, 2009 | clinicaltrials |
Data updated 23 days agoSource updated May 7, 2009source: clinicaltrials